企業プロフィール
Satsuma 株価・ニュース・カタリスト
- ティッカー:
- STSA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for STSA.
企業概要
事業概要
Satsuma Pharmaceuticals was a migraine and CNS company focused on acute treatment delivery before its acquisition and restructuring. Its story centered on using inhaled delivery for migraine therapy.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ before acquisition, Satsuma sat in specialty biotechnology.
ビジネスモデルの特徴
The company depended on clinical validation, delivery technology, and the commercial opportunity in migraine care.
バイオ業界での位置付け
Satsuma is best treated as a historical CNS and specialty-pharma case rather than a live catalyst name.
今後のカタリスト
- Satsuma’s catalyst set is now mostly legacy and transition-related, with any remaining update focused on how the migraine asset base is being handled. The market is no longer treating it like a fresh standalone growth story.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。